Mirae Asset Global Investments
KRTX

Mirae Asset Global Investments’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Mirae Asset Global Investments’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,640
Closed -$3.2M – 2724
2023
Q1 		$3.2M Buy
17,640
+3,170
+22% +$606K 0.01% 992
2022
Q4 		$2.84M Buy
14,470
+1,235
+9% +$265K 0.01% 1000
2022
Q3 		$2.98M Buy
+13,235
New +$2.68M 0.01% 985

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mirae Asset Global Investments's KRTX Position: Q2 2023 in Review

Mirae Asset Global Investments sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q2 2023, closing a stake of 17,640 shares — an estimated $3.2M sold.

Mirae Asset Global Investments first reported a position in KRTX in Q3 2022 and held it in 3 quarters. The position peaked at $3.2M in Q1 2023. 289 funds tracked by Wall St. Rank hold KRTX as of Q2 2023.

  • Mirae Asset Global Investments reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Mirae Asset Global Investments sold 17,640 Karuna Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $3.2M.
  • Mirae Asset Global Investments first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
  • Mirae Asset Global Investments's Karuna Therapeutics, Inc. Common Stock position peaked at $3.2M in Q1 2023.
  • 289 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Mirae Asset Global Investments's 13F filing for Q2 2023, filed 10 Aug 2023.